Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Imaging of the aging brain and development of MRI signal abnormalities.

Chabriat H, Jouvent E.

Rev Neurol (Paris). 2020 Mar 27. pii: S0035-3787(20)30467-7. doi: 10.1016/j.neurol.2019.12.009. [Epub ahead of print] Review.

PMID:
32229042
2.

Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.

Mancuso M, Arnold M, Bersano A, Burlina A, Chabriat H, Debette S, Enzinger C, Federico A, Filla A, Finsterer J, Hunt D, Lesnik Oberstein S, Tournier-Lasserve E, Markus HS.

Eur J Neurol. 2020 Mar 20. doi: 10.1111/ene.14183. [Epub ahead of print]

PMID:
32196841
3.

Clinical features related to CSF level of amyloid Aβ42 and Aβ40 proteins in presence of lobar microbleeds.

Girard-Stein L, Dumurgier J, Paquet C, Chabriat H.

Rev Neurol (Paris). 2020 Mar 14. pii: S0035-3787(20)30378-7. doi: 10.1016/j.neurol.2020.02.001. [Epub ahead of print]

PMID:
32183983
4.

Incident cerebral lacunes: A review.

Ling Y, Chabriat H.

J Cereb Blood Flow Metab. 2020 Mar 3:271678X20908361. doi: 10.1177/0271678X20908361. [Epub ahead of print] No abstract available.

PMID:
32126874
5.

Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.

Chabriat H, Bassetti CL, Marx U, Audoli-Inthavong ML, Sors A, Lambert E, Wattez M, Hermann DM; RESTORE BRAIN study investigators.

Lancet Neurol. 2020 Mar;19(3):226-233. doi: 10.1016/S1474-4422(20)30004-1.

PMID:
32085836
6.

Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study.

Chabriat H, Bassetti CL, Marx U, Picarel-Blanchot F, Sors A, Gruget C, Saba B, Wattez M, Audoli ML, Hermann DM.

Trials. 2020 Feb 3;21(1):136. doi: 10.1186/s13063-020-4072-2.

7.

Covert Brain Infarcts: Look at Extra and Intracranial Vessels.

Chabriat H.

Stroke. 2020 Jan;51(1):2-3. doi: 10.1161/STROKEAHA.119.027445. Epub 2019 Nov 26. No abstract available.

PMID:
31766981
8.

Artery occlusion independently predicts unfavorable outcome in cervical artery dissection.

Traenka C, Grond-Ginsbach C, Goeggel Simonetti B, Metso TM, Debette S, Pezzini A, Kloss M, Majersik JJ, Southerland AM, Leys D, Baumgartner R, Caso V, Béjot Y, De Marchis GM, Fischer U, Polymeris A, Sarikaya H, Thijs V, Worrall BB, Bersano A, Brandt T, Gensicke H, Bonati LH, Touzeé E, Martin JJ, Chabriat H, Tatlisumak T, Arnold M, Engelter ST, Lyrer P; CADISP-Plus Study Group.

Neurology. 2020 Jan 14;94(2):e170-e180. doi: 10.1212/WNL.0000000000008654. Epub 2019 Nov 22.

9.

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Lessons From Neuroimaging.

Jouvent E, Duering M, Chabriat H.

Stroke. 2020 Jan;51(1):21-28. doi: 10.1161/STROKEAHA.119.024152. Epub 2019 Nov 22. No abstract available.

PMID:
31752612
10.

Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline.

Jokinen H, Koikkalainen J, Laakso HM, Melkas S, Nieminen T, Brander A, Korvenoja A, Rueckert D, Barkhof F, Scheltens P, Schmidt R, Fazekas F, Madureira S, Verdelho A, Wallin A, Wahlund LO, Waldemar G, Chabriat H, Hennerici M, O'Brien J, Inzitari D, Lötjönen J, Pantoni L, Erkinjuntti T.

Stroke. 2020 Jan;51(1):170-178. doi: 10.1161/STROKEAHA.119.026170. Epub 2019 Nov 8.

11.

Cerebral Amyloid Angiopathy Related Inflammation With Prominent Meningeal Involvement. A Report of 2 Cases.

Aghetti A, Sène D, Polivka M, Shor N, Lechtman S, Chabriat H, Jouvent E, Guey S.

Front Neurol. 2019 Sep 23;10:984. doi: 10.3389/fneur.2019.00984. eCollection 2019.

12.

Response by Di Meglio et al to Letter Regarding Article, "Intracranial Extension of Extracranial Vertebral Artery Dissection Is Associated With an Increased Risk of Ischemic Events".

Di Meglio L, Mazighi M, Chabriat H.

Stroke. 2019 Nov;50(11):e327. doi: 10.1161/STROKEAHA.119.027043. Epub 2019 Sep 20. No abstract available.

PMID:
31537187
13.

Leukoencephalopathy with calcifications and cysts (LCC): 5 cases and literature review.

Osman O, Labrune P, Reiner P, Sarov M, Nasser G, Riant F, Tournier-Lasserve E, Chabriat H, Denier C.

Rev Neurol (Paris). 2020 Mar;176(3):170-179. doi: 10.1016/j.neurol.2019.06.006. Epub 2019 Sep 11.

PMID:
31521395
14.

Lamotrigine in the Prevention of Migraine With Aura: A Narrative Review.

Buch D, Chabriat H.

Headache. 2019 Sep;59(8):1187-1197. doi: 10.1111/head.13615. Epub 2019 Aug 29. Review.

PMID:
31468532
15.

Alteration of the Cortex Shape as a Proxy of White Matter Swelling in Severe Cerebral Small Vessel Disease.

De Guio F, Germanaud D, Lefèvre J, Fischer C, Mangin JF, Chabriat H, Jouvent E.

Front Neurol. 2019 Jul 10;10:753. doi: 10.3389/fneur.2019.00753. eCollection 2019.

16.

Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy.

Hervé D, Ibos-Augé N, Calvière L, Rogan C, Labeyrie MA, Guichard JP, Godin O, Kossorotoff M, Habert MO, Lasserve ET, Chevret S, Chabriat H.

Neurology. 2019 Jul 23;93(4):e388-e397. doi: 10.1212/WNL.0000000000007819. Epub 2019 Jun 25.

17.

Intracranial Extension of Extracranial Vertebral Dissection Is Associated With an Increased Risk of Ischemic Events.

Di Meglio L, Mazighi M, Reiner P, Peres R, Guichard JP, Labeyrie MA, Debette S, Chabriat H, Cognat E.

Stroke. 2019 Aug;50(8):2231-2233. doi: 10.1161/STROKEAHA.119.025227. Epub 2019 Jun 21.

PMID:
31221053
18.

Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.

Wilson D, Ambler G, Lee KJ, Lim JS, Shiozawa M, Koga M, Li L, Lovelock C, Chabriat H, Hennerici M, Wong YK, Mak HKF, Prats-Sánchez L, Martínez-Domeño A, Inamura S, Yoshifuji K, Arsava EM, Horstmann S, Purrucker J, Lam BYK, Wong A, Kim YD, Song TJ, Schrooten M, Lemmens R, Eppinger S, Gattringer T, Uysal E, Tanriverdi Z, Bornstein NM, Assayag EB, Hallevi H, Tanaka J, Hara H, Coutts SB, Hert L, Polymeris A, Seiffge DJ, Lyrer P, Algra A, Kappelle J, Al-Shahi Salman R, Jäger HR, Lip GYH, Mattle HP, Panos LD, Mas JL, Legrand L, Karayiannis C, Phan T, Gunkel S, Christ N, Abrigo J, Leung T, Chu W, Chappell F, Makin S, Hayden D, Williams DJ, Kooi ME, van Dam-Nolen DHK, Barbato C, Browning S, Wiegertjes K, Tuladhar AM, Maaijwee N, Guevarra C, Yatawara C, Mendyk AM, Delmaire C, Köhler S, van Oostenbrugge R, Zhou Y, Xu C, Hilal S, Gyanwali B, Chen C, Lou M, Staals J, Bordet R, Kandiah N, de Leeuw FE, Simister R, van der Lugt A, Kelly PJ, Wardlaw JM, Soo Y, Fluri F, Srikanth V, Calvet D, Jung S, Kwa VIH, Engelter ST, Peters N, Smith EE, Yakushiji Y, Orken DN, Fazekas F, Thijs V, Heo JH, Mok V, Veltkamp R, Ay H, Imaizumi T, Gomez-Anson B, Lau KK, Jouvent E, Rothwell PM, Toyoda K, Bae HJ, Marti-Fabregas J, Werring DJ; Microbleeds International Collaborative Network.

Lancet Neurol. 2019 Jul;18(7):653-665. doi: 10.1016/S1474-4422(19)30197-8. Epub 2019 May 23. Erratum in: Lancet Neurol. 2019 Sep;18(9):e8. Lancet Neurol. 2020 Feb;19(2):e2.

19.

Correction: The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant.

Rutten JW, Van Eijsden BJ, Duering M, Jouvent E, Opherk C, Pantoni L, Federico A, Dichgans M, Markus HS, Chabriat H, Oberstein SAJL.

Genet Med. 2019 Aug;21(8):1895. doi: 10.1038/s41436-018-0306-z.

20.

Increased PKR level in human CADASIL brains.

Cognat E, Tible M, Methnani I, Chabriat H, Adle-Biassette H, Hugon J, Paquet C.

Virchows Arch. 2018 Dec;473(6):771-774. doi: 10.1007/s00428-018-2425-y. Epub 2018 Aug 2.

PMID:
30073405
21.

Determinants and outcome of multiple and early recurrent cervical artery dissections.

Compter A, Schilling S, Vaineau CJ, Goeggel-Simonetti B, Metso TM, Southerland A, Pezzini A, Kloss M, Touzé E, Worrall BB, Thijs V, Bejot Y, Reiner P, Grond-Ginsbach C, Bersano A, Brandt T, Caso V, Lyrer PA, Traenka C, Lichy C, Martin JJ, Leys D, Sarikaya H, Baumgartner RW, Jung S, Fischer U, Engelter ST, Dallongeville J, Chabriat H, Tatlisumak T, Bousser MG, Arnold M, Debette S; CADISP-plus Consortium.

Neurology. 2018 Aug 21;91(8):e769-e780. doi: 10.1212/WNL.0000000000006037. Epub 2018 Aug 1.

PMID:
30068628
22.

Different Types of White Matter Hyperintensities in CADASIL.

Duchesnay E, Hadj Selem F, De Guio F, Dubois M, Mangin JF, Duering M, Ropele S, Schmidt R, Dichgans M, Chabriat H, Jouvent E.

Front Neurol. 2018 Jul 10;9:526. doi: 10.3389/fneur.2018.00526. eCollection 2018.

23.

The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant.

Rutten JW, Van Eijsden BJ, Duering M, Jouvent E, Opherk C, Pantoni L, Federico A, Dichgans M, Markus HS, Chabriat H, Lesnik Oberstein SAJ.

Genet Med. 2019 Mar;21(3):676-682. doi: 10.1038/s41436-018-0088-3. Epub 2018 Jul 22. Erratum in: Genet Med. 2018 Sep 20;:.

24.

Altered dynamics of neurovascular coupling in CADASIL.

Huneau C, Houot M, Joutel A, Béranger B, Giroux C, Benali H, Chabriat H.

Ann Clin Transl Neurol. 2018 May 21;5(7):788-802. doi: 10.1002/acn3.574. eCollection 2018 Jul.

25.

Why Are Only Some Subcortical Ischemic Lesions on Diffusion Magnetic Resonance Imaging Associated With Stroke Symptoms in Small Vessel Disease?

Osman O, De Guio F, Chabriat H, Jouvent E.

Stroke. 2018 Aug;49(8):1920-1923. doi: 10.1161/STROKEAHA.118.021342.

PMID:
29986933
26.

Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders.

Paquet C, Bouaziz-Amar E, Cognat E, Volpe-Gillot L, Haddad V, Mahieux F, Dekimeche S, Defontaines B, Chabriat H, Belin C, Texeira A, Goutagny S, Questel F, Azuar J, Sellier PO, Laplanche JL, Hugon J, Dumurgier J.

J Alzheimers Dis. 2018;64(3):889-897. doi: 10.3233/JAD-180240.

PMID:
29966201
27.

Optical Coherence Tomography Angiography of Familial Retinal Arteriolar Tortuosity.

Giocanti-Auregan A, Gaudric A, Buffon F, Mine M, Delahaye-Mazza C, Cohen SY, Erginay A, Chabriat H, Lasserve ET, Krivosic V.

Ophthalmic Surg Lasers Imaging Retina. 2018 Jun 1;49(6):397-401. doi: 10.3928/23258160-20180601-03.

PMID:
29927466
28.

Validation and Optimization of BIANCA for the Segmentation of Extensive White Matter Hyperintensities.

Ling Y, Jouvent E, Cousyn L, Chabriat H, De Guio F.

Neuroinformatics. 2018 Apr;16(2):269-281. doi: 10.1007/s12021-018-9372-2.

PMID:
29594711
29.

Can anticoagulation therapy in cerebral venous thrombosis associated with Behçet's disease be stopped without relapse?

Roriz M, Crassard I, Lechtman S, Saadoun D, Champion K, Wechsler B, Chabriat H, Sène D.

Rev Neurol (Paris). 2018 Mar;174(3):162-166. doi: 10.1016/j.neurol.2017.06.021. Epub 2018 Mar 7.

PMID:
29523353
30.

French clinical practice guidelines for Moyamoya angiopathy.

Hervé D, Kossorotoff M, Bresson D, Blauwblomme T, Carneiro M, Touze E, Proust F, Desguerre I, Alamowitch S, Bleton JP, Borsali A, Brissaud E, Brunelle F, Calviere L, Chevignard M, Geffroy-Greco G, Faesch S, Habert MO, De Larocque H, Meyer P, Reyes S, Thines L, Tournier-Lasserve E, Chabriat H.

Rev Neurol (Paris). 2018 May;174(5):292-303. doi: 10.1016/j.neurol.2017.12.002. Epub 2018 Mar 5. No abstract available.

PMID:
29519672
31.

Fatal Aβ cerebral amyloid angiopathy 4 decades after a dural graft at the age of 2 years.

Hervé D, Porché M, Cabrejo L, Guidoux C, Tournier-Lasserve E, Nicolas G, Adle-Biassette H, Plu I, Chabriat H, Duyckaerts C.

Acta Neuropathol. 2018 May;135(5):801-803. doi: 10.1007/s00401-018-1828-9. Epub 2018 Mar 5. No abstract available.

PMID:
29508058
32.

Clinical correlates of longitudinal MRI changes in CADASIL.

Ling Y, De Guio F, Jouvent E, Duering M, Hervé D, Guichard JP, Godin O, Dichgans M, Chabriat H.

J Cereb Blood Flow Metab. 2019 Jul;39(7):1299-1305. doi: 10.1177/0271678X18757875. Epub 2018 Feb 5.

PMID:
29400120
33.

Differential diagnosis between sarcoidosis and granulomatosis with polyangiitis in a patient with leptomeningeal, cavernous sinus and pituitary lesions.

Marques C, Roriz M, Chabriat H, Buffon-Porcher F, Cognat E.

QJM. 2017 Oct 1;110(10):691-692. doi: 10.1093/qjmed/hcx135. No abstract available.

PMID:
29025147
34.

Reaction Time Is Negatively Associated with Corpus Callosum Area in the Early Stages of CADASIL.

Delorme S, De Guio F, Reyes S, Jabouley A, Chabriat H, Jouvent E.

AJNR Am J Neuroradiol. 2017 Nov;38(11):2094-2099. doi: 10.3174/ajnr.A5378. Epub 2017 Sep 14.

35.

Arterial branching and basal ganglia lacunes: A study in pure small vessel disease.

Moreton FC, Düring M, Phan T, Srikanth V, Beare R, Huang X, Jouvent E, Chabriat H, Dichgans M, Muir KW.

Eur Stroke J. 2017 Sep;2(3):264-271. doi: 10.1177/2396987317718450. Epub 2017 Jul 7.

36.

Cerebral Microbleeds and the Risk of Incident Ischemic Stroke in CADASIL (Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy).

Puy L, De Guio F, Godin O, Duering M, Dichgans M, Chabriat H, Jouvent E.

Stroke. 2017 Oct;48(10):2699-2703. doi: 10.1161/STROKEAHA.117.017839. Epub 2017 Aug 25.

PMID:
28842512
37.

Diffusion magnetic resonance imaging in cerebral small vessel disease.

Lyoubi-Idrissi AL, Jouvent E, Poupon C, Chabriat H.

Rev Neurol (Paris). 2017 Apr;173(4):201-210. doi: 10.1016/j.neurol.2017.03.005. Epub 2017 Apr 6. Review.

PMID:
28392060
38.

Cortical Superficial Siderosis in Different Types of Cerebral Small Vessel Disease.

Wollenweber FA, Baykara E, Zedde M, Gesierich B, Achmüller M, Jouvent E, Viswanathan A, Ropele S, Chabriat H, Schmidt R, Opherk C, Dichgans M, Linn J, Duering M.

Stroke. 2017 May;48(5):1404-1407. doi: 10.1161/STROKEAHA.117.016833. Epub 2017 Mar 31.

PMID:
28364025
39.

Pathogenesis of white matter changes in cerebral small vessel diseases: beyond vessel-intrinsic mechanisms.

Joutel A, Chabriat H.

Clin Sci (Lond). 2017 Apr 25;131(8):635-651. doi: 10.1042/CS20160380. Review.

PMID:
28351960
40.

Focal Macroscopic Cortical Lesions in Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.

Lyoubi-Idrissi A, De Guio F, Chabriat H, Jouvent E.

Stroke. 2017 May;48(5):1408-1411. doi: 10.1161/STROKEAHA.116.015724. Epub 2017 Mar 27.

PMID:
28348068
41.

Cervical artery dissection in patients ≥60 years: Often painless, few mechanical triggers.

Traenka C, Dougoud D, Simonetti BG, Metso TM, Debette S, Pezzini A, Kloss M, Grond-Ginsbach C, Majersik JJ, Worrall BB, Leys D, Baumgartner R, Caso V, Béjot Y, Compter A, Reiner P, Thijs V, Southerland AM, Bersano A, Brandt T, Gensicke H, Touzé E, Martin JJ, Chabriat H, Tatlisumak T, Lyrer P, Arnold M, Engelter ST; CADISP-Plus Study Group.

Neurology. 2017 Apr 4;88(14):1313-1320. doi: 10.1212/WNL.0000000000003788. Epub 2017 Mar 3.

PMID:
28258079
42.

Neurosarcoidosis: leptomeninigeal, cavernous sinus and pituitary involvement.

Bicart-Sée L, Roriz M, Chabriat H, Buffon-Porcher F, Cognat E.

QJM. 2017 Jun 1;110(6):397-398. doi: 10.1093/qjmed/hcx037. No abstract available.

PMID:
28186582
43.

Different types of white matter hyperintensities in CADASIL: Insights from 7-Tesla MRI.

De Guio F, Vignaud A, Chabriat H, Jouvent E.

J Cereb Blood Flow Metab. 2018 Sep;38(9):1654-1663. doi: 10.1177/0271678X17690164. Epub 2017 Jan 27.

44.

Predictors and Clinical Impact of Incident Lacunes in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.

Ling Y, De Guio F, Duering M, Jouvent E, Hervé D, Godin O, Dichgans M, Chabriat H.

Stroke. 2017 Feb;48(2):283-289. doi: 10.1161/STROKEAHA.116.015750. Epub 2016 Dec 29.

PMID:
28034964
45.

Lower Magnetization Transfer Ratio in the Forceps Minor Is Associated with Poorer Gait Velocity in Older Adults.

Seiler S, Pirpamer L, Gesierich B, Hofer E, Duering M, Pinter D, Jouvent E, Fazekas F, Mangin JF, Chabriat H, Ropele S, Schmidt R.

AJNR Am J Neuroradiol. 2017 Mar;38(3):500-506. doi: 10.3174/ajnr.A5036. Epub 2016 Dec 15.

46.

Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke).

von Kummer R, Mori E, Truelsen T, Jensen JS, Grønning BA, Fiebach JB, Lovblad KO, Pedraza S, Romero JM, Chabriat H, Chang KC, Dávalos A, Ford GA, Grotta J, Kaste M, Schwamm LH, Shuaib A, Albers GW; DIAS-4 Investigators.

Stroke. 2016 Dec;47(12):2880-2887. Epub 2016 Nov 1.

PMID:
27803391
47.

Prediction of 3-year clinical course in CADASIL.

Jouvent E, Duchesnay E, Hadj-Selem F, De Guio F, Mangin JF, Hervé D, Duering M, Ropele S, Schmidt R, Dichgans M, Chabriat H.

Neurology. 2016 Oct 25;87(17):1787-1795. Epub 2016 Sep 30.

48.

Disruption of a miR-29 binding site leading to COL4A1 upregulation causes pontine autosomal dominant microangiopathy with leukoencephalopathy.

Verdura E, Hervé D, Bergametti F, Jacquet C, Morvan T, Prieto-Morin C, Mackowiak A, Manchon E, Hosseini H, Cordonnier C, Girard-Buttaz I, Rosenstingl S, Hagel C, Kuhlenbaümer G, Leca-Radu E, Goux D, Fleming L, Van Agtmael T, Chabriat H, Chapon F, Tournier-Lasserve E.

Ann Neurol. 2016 Nov;80(5):741-753. doi: 10.1002/ana.24782. Epub 2016 Oct 19.

PMID:
27666438
49.

A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms.

Baykara E, Gesierich B, Adam R, Tuladhar AM, Biesbroek JM, Koek HL, Ropele S, Jouvent E; Alzheimer's Disease Neuroimaging Initiative, Chabriat H, Ertl-Wagner B, Ewers M, Schmidt R, de Leeuw FE, Biessels GJ, Dichgans M, Duering M.

Ann Neurol. 2016 Oct;80(4):581-92. doi: 10.1002/ana.24758. Epub 2016 Aug 29.

PMID:
27518166
50.

Cerebral Microhemorrhages: Significance, Associations, Diagnosis, and Treatment.

Jouvent E, Puy L, Chabriat H.

Curr Treat Options Neurol. 2016 Aug;18(8):35. doi: 10.1007/s11940-016-0418-1. Review.

PMID:
27314427

Supplemental Content

Loading ...
Support Center